Cowen Prime Advisors LLC - CYTOSORBENTS CORP ownership

CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 96 filers reported holding CYTOSORBENTS CORP in Q3 2021. The put-call ratio across all filers is 2.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
Cowen Prime Advisors LLC ownership history of CYTOSORBENTS CORP
ValueSharesWeighting
Q2 2023$151,861
+134290.3%
42,301
-8.1%
0.05%
+15.6%
Q1 2023$113
+76.6%
46,050
+11.8%
0.04%
+73.1%
Q4 2022$64
-99.9%
41,200
-2.4%
0.03%
-21.2%
Q3 2022$57,000
-38.0%
42,2000.0%0.03%
-36.5%
Q2 2022$92,000
+84.0%
42,200
+170.5%
0.05%
+147.6%
Q1 2022$50,000
+212.5%
15,600
+316.0%
0.02%
+320.0%
Q4 2021$16,000
+60.0%
3,750
+212.5%
0.01%
+25.0%
Q3 2021$10,000
-89.1%
1,200
-97.2%
0.00%
-92.3%
Q2 2020$92,00042,2000.05%
Other shareholders
CYTOSORBENTS CORP shareholders Q3 2021
NameSharesValueWeighting ↓
Skylands Capital, LLC 815,869$3,141,0000.46%
Sargent Investment Group, LLC 499,010$1,921,0000.36%
Anson Funds Management LP 74,440$287,0000.33%
One68 Global Capital, LLC 39,241$151,0000.33%
Granahan Investment Management 678,618$2,613,0000.12%
Winning Points Advisors, LLC 30,000$115,0000.07%
Avenir Corp 150,600$580,0000.06%
HighMark Wealth Management LLC 10,000$38,0000.04%
Wealthcare Advisory Partners LLC 62,279$240,0000.03%
GSA CAPITAL PARTNERS LLP 64,970$250,0000.03%
View complete list of CYTOSORBENTS CORP shareholders